STUDIEBUREAU EUREPLAN
ActiveSummary
The computed 12-month bankruptcy probability of STUDIEBUREAU EUREPLAN is 2.0% (moderate). The 2025 annual accounts show negative equity (-€243,748) and a net result of -€15,026. Equity is shrinking by about 5.7% per year across the filed financial years. Its solvency ranks better than 5% of 2,547 sector peers (NACE 71, financial year 2025). The company has been active since 2012 and the Belgian Official Gazette contains no insolvency or warning signals.
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
28-09
NBB filing
Annual accounts filed
financial year 2025 · abbreviated format · 59 days late
2025
26-07
NBB filing
Annual accounts filed
financial year 2024 · abbreviated format
2024
23-08
NBB filing
Annual accounts filed
financial year 2023 · abbreviated format · 23 days late
2023
28-08
NBB filing
Annual accounts filed
financial year 2022 · abbreviated format · 28 days late
2022
31-12
Financial
Back to profitnet €26,013
Net result €26,013 after 4 loss-making years.
26-08
NBB filing
Annual accounts filed
financial year 2021 · abbreviated format · 26 days late
2021
30-07
NBB filing
Annual accounts filed
financial year 2020 · abbreviated format
2020
08-09
NBB filing
Annual accounts filed
financial year 2019 · abbreviated format · 39 days late
2019
31-12
Financial
Weakest financial yearnet -€182,454
Net result drops to -€182,454, the lowest in the series; recovery starts the following year.
04-07
NBB filing
Annual accounts filed
financial year 2018 · micro format
2018
03-07
NBB filing
Annual accounts filed
financial year 2017 · micro format
2017
06-07
NBB filing
Annual accounts filed
financial year 2016 · micro format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 13 annual accounts filed, the latest 10 are here; all 13 are under Financials.
0 of 4 deeds read
About the unread acts
We know of 4 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.